Literature DB >> 23884705

Validation of the 2010 American College of Rheumatology preliminary diagnostic criteria for fibromyalgia in an Iranian population.

Ali Bidari1, Morteza Hassanzadeh, Banafsheh Ghavidel Parsa, Nahid Kianmehr, Ali Kabir, Sara Pirhadi, Mohammad Sayfi, Mehrangiz Toutounchi, Fariba Fattahi, Fereidoon Zandi Karimi.   

Abstract

The aim of this study was to validate the 2010 American College of Rheumatology (ACR) preliminary criteria for fibromyalgia (FM) in an Iranian population. In this multicenter prospective study, we enrolled 168 FM patients and 110 controls. All participants underwent dolorimetry examination by study assessors and completed a questionnaire containing variables of both the ACR 2010 preliminary and ACR 1990 criteria. We compared the performance of the ACR 2010 criteria with the expert diagnosis as well as the ACR 1990 criteria. Receiver operator characteristic analyses and Youden index were used to evaluate the test characteristics of a set of different cutoff points for two subcomponents of ACR 2010 criteria including widespread pain index (WPI) and symptom severity (SS) scale. Considering expert diagnosis as the gold standard, the ACR 2010 criteria showed comparable specificity with ACR 1990 (92.8 vs. 88.3 %, P = 0.073), but lower sensitivity (58.9 vs. 71.4 %, P = 0.003) and a tendency for lower accuracy (72.4 vs. 78.4 %, P = 0.105). Applying the ACR 1990 criteria as the gold standard, we observed a trend toward an increase in overall accuracy (72.4 vs. 79.1 %, P = 0.064). Optimal test characteristics were achieved for WPI ≥6 and SS scale score ≥4 and improved sensitivity and accuracy of ACR 2010 criteria when compared to expert, 76.1 and 81.7, respectively. The preliminary ACR 2010 criteria performed less desirably in terms of sensitivity in our set of Iranian patients. Selecting lower cutoff points as WPI ≥6 and SS scale score ≥4 improved the diagnostic values of the criteria.

Entities:  

Mesh:

Year:  2013        PMID: 23884705     DOI: 10.1007/s00296-013-2829-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  23 in total

1.  Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.

Authors:  Frederick Wolfe; Daniel J Clauw; Mary-Ann Fitzcharles; Don L Goldenberg; Winfried Häuser; Robert S Katz; Philip Mease; Anthony S Russell; I Jon Russell; John B Winfield
Journal:  J Rheumatol       Date:  2011-02-01       Impact factor: 4.666

2.  Should rheumatologists retain ownership of fibromyalgia?

Authors:  Yoram Shir; Mary-Ann Fitzcharles
Journal:  J Rheumatol       Date:  2009-04       Impact factor: 4.666

Review 3.  Fibromyalgia syndrome a decade later: what have we learned?

Authors:  D L Goldenberg
Journal:  Arch Intern Med       Date:  1999-04-26

4.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

Review 5.  Is fibromyalgia a distinct clinical entity? The approving rheumatologist's evidence.

Authors:  M A Fitzcharles
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-09       Impact factor: 4.098

Review 6.  Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes.

Authors:  Muhammad B Yunus
Journal:  Semin Arthritis Rheum       Date:  2007-03-13       Impact factor: 5.532

7.  Inaccuracy in the diagnosis of fibromyalgia syndrome: analysis of referrals.

Authors:  M-A Fitzcharles; P Boulos
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

8.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

9.  Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

Authors:  R M Bennett; S R Clark; S M Campbell; C S Burckhardt
Journal:  Arthritis Rheum       Date:  1992-10

10.  The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Pantelis Panopalis; Henri Ménard; Yoram Shir; Fred Wolfe
Journal:  BMC Musculoskelet Disord       Date:  2012-09-20       Impact factor: 2.362

View more
  13 in total

1.  Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting.

Authors:  Sakir Ahmed; Amita Aggarwal; Able Lawrence
Journal:  Rheumatol Int       Date:  2019-05-17       Impact factor: 2.631

Review 2.  A narrative review on the difficulties associated with fibromyalgia diagnosis.

Authors:  Dinesh Kumbhare; Sara Ahmed; Scott Watter
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-12-07       Impact factor: 5.346

3.  The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Banafsheh Ghavidel Parsa; Alireza Amir Maafi; Afrooz Haghdoost; Yasaman Arabi; Monire Khojamli; Gelayol Chatrnour; Ali Bidari
Journal:  Rheumatol Int       Date:  2014-01-01       Impact factor: 2.631

4.  Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.

Authors:  Ali Bidari; Ehsan Moazen-Zadeh; Banafsheh Ghavidel-Parsa; Shahrzad Rahmani; Sajjad Hosseini; Amir Hassankhani
Journal:  Daru       Date:  2019-03-14       Impact factor: 3.117

Review 5.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

6.  Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Authors:  Ali Bidari; Morteza Hassanzadeh; Mohamad-Farzam Mohabat; Elham Talachian; Effat Merghati Khoei
Journal:  Rheumatol Int       Date:  2013-10-29       Impact factor: 2.631

7.  Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population.

Authors:  Ali Bidari; Banafsheh Ghavidel-Parsa; Alireza Amir Maafi; Ali Montazeri; Babak Ghalehbaghi; Amir Hassankhani; Yasaman Aarabi; Afrooz Haghdoost
Journal:  Rheumatol Int       Date:  2015-08-08       Impact factor: 2.631

Review 8.  The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Alireza Amir Maafi; Babak Ghalebaghi
Journal:  Korean J Pain       Date:  2015-07-01

9.  Serum Vitamin D Status in Iranian Fibromyalgia Patients: according to the Symptom Severity and Illness Invalidation.

Authors:  Alireza Amir Maafi; Banafsheh Ghavidel-Parsa; Afrooz Haghdoost; Yasaman Aarabi; Asghar Hajiabbasi; Irandokht Shenavar Masooleh; Habib Zayeni; Babak Ghalebaghi; Amir Hassankhani; Ali Bidari
Journal:  Korean J Pain       Date:  2016-07-01

Review 10.  Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives.

Authors:  Carmen M Galvez-Sánchez; Gustavo A Reyes Del Paso
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.